Spectrum Pharmaceuticals Highlights 13 Abstracts at the 55th Annual...
Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced key presentations of clinical and scientific data at the 55th Annual Meeting of the American Society of Hematology , being held in New Orleans, Louisiana, from December ... (more)
Spectrum Pharmaceuticals Inc - 10-Q/a - Management's Discussion and...
This Quarterly Report on Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, in reliance upon the safe harbor provisions of the Private Securities Litigation ... (more)
Tekmira Provides Corporate Update and Announces Third Quarter 2013 Results
We are also currently evaluating several preclinical candidates in diverse therapeutic areas, with a focus on rare diseases where the molecular target is found in the liver.
Spectrum Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript
Good day, ladies and gentlemen. Thank you for standing by, and welcome to the third quarter 2013 financial results conference call.
Spectrum Pharmaceuticals Reports Financial Results for Third Quarter 2013
'We are looking forward to filing the NDA for Belinostat before the end of this year and expect to bring this important treatment option to patients next year.
Spectrum Pharmaceuticals to Present Corporate Update at the Credit...
Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview of the Company's business strategy and commercial and development-stage programs will be given at the Credit Suisse 2013 Healthcare Conference being ... (more)